{
  "docId": "019dd923-622c-750b-8b9a-3bcd52c6e583",
  "docSlug": "f06b0b5d2079",
  "documentTitle": "Soleno Therapeutics (SLNO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-08-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 269,
  "pageCount": 415,
  "prevPage": 268,
  "nextPage": 270,
  "slideType": "testimonial",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses direct quotes from an Anthem VP to undermine the product's market viability.",
  "elementsJson": [
    "paragraph",
    "quote_block"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-3bcd52c6e583/269",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583#slide-269",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "I don't think that you're going to see many payers covering that right now. I don't see it. And I can tell you that Anthem Elevance is not one of them.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2ad-ab201d996779",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.86,
        "x": 0.07,
        "y": 0.56
      },
      "kind": "list",
      "text": "Anthem enthusiasm for covering Vykat is 2 or 3 out of 10; unlikely to cover full amount even if covered",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a74c1ca3-a5ae-49fc-8457-a60d26b865c3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.86,
        "x": 0.07,
        "y": 0.41
      },
      "kind": "list",
      "text": "Anthem extremely negative about Vykat potential – “I don’t see it”; “perceived very negatively”",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ca7d4ef5-d32d-49af-8622-116417a79c26",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.86,
        "x": 0.07,
        "y": 0.71
      },
      "kind": "list",
      "text": "Anthem highly skeptical of “limited” clinical data – “no efficacy”; don’t expect to cover it in “near future”",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f7a80746-964c-4d7f-9f37-45bcb7d9eebd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.86,
        "x": 0.07,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "We begin with an Anthem VP who indicated they had not approved Vykat coverage and that “I don’t see that in the near future...I don’t because there’s no efficacy”; “it would be perceived very negatively...I don’t think you’re going to see many payers covering that right now...I don’t see it...I can tell you that Anthem Elevance is not one of them”; “this is going to be very difficult...there’s just limited clinical data...that’s a big red flag, especially at this astronomical price.”",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1af35ac6-a716-4bfc-870b-7ff143877bcf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“I don’t see that in the near future...I don’t because there’s no efficacy”; “it would be perceived very negatively...I don’t think you’re going to see many payers covering that right now...I don’t see it...I can tell you that Anthem Elevance is not one of them”; “this is going to be very difficult...there’s just limited clinical data...that’s a big red flag, especially at this astronomical price.” — Vice President at Elevance (previously Anthem)",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2ad-acbf9161d380",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5442cb45-02a4-4584-a004-3b270b1e9f9f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "We spoke with two large insurers whose color corroborated the supernormal denial rates indicated by physicians submitting start forms – Elevance, formerly known as Anthem, which covers 50MM lives; and Blue Shield of California, with 6MM members.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "40dcc9b6-594b-4195-8d5e-3952c24c4eaa",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "authority-citation",
      "slug": null,
      "matchId": "907a2280-9139-4bea-8b40-6477744a7b07",
      "evidence": "Uses VP-level expert testimony to validate investment thesis",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}